$GEN #Genmab A/S Genmab (Hold, TP: DKK2400.00) - US Darzalex shows recovery: In its Q2 report, Johnson &amp; Johnson noted lower Darzalex sales than we expected, at USD901m, below our estimate of cUSD936m. US sales were strong at USD492m (we… https://t.co/nzpbab3sNb #equity #stocks https://t.co/SEagprKrZI